SCHEMBL6716004

SCHEMBL6716004

CCCCC(Cc1ccc(OCCNC(=O)c2ccc(OC)nc2)cc1)C(=O)O

nearest known ligand 0.52

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PPARG P37231 8/20 0.52
PPARA Q07869 4/20 0.52
PTGES O14684 4/20 0.52
ALOX5 P09917 4/20 0.52
NPC1 O15118 4/20 0.47
MEN1 O00255 3/20 0.47
KMT2A Q03164 3/20 0.47
RAB9A P51151 2/20 0.47
MMP9 P14780 1/20 0.46
MMP12 P39900 1/20 0.46
PPARD Q03181 3/20 0.46
MAPT P10636 2/20 0.42
TP53 P04637 1/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
NFKB1 P19838 1/20 0.42
NFKB2 Q00653 1/20 0.42
RELA Q04206 1/20 0.42
LMNA P02545 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6714855 0.91 EPHX2 (0.48) PPARGPPARAPTGESALOX5NPC1
SCHEMBL6715078 0.91 PPARG (0.50) PPARGPPARAPTGESALOX5NPC1
SCHEMBL6714929 0.90 PPARG (0.52) PPARGPPARAPTGESALOX5NPC1
SCHEMBL6715196 0.89 PPARG (0.51) PPARGPPARAPTGESALOX5NPC1
SCHEMBL6715805 0.86 PPARG (0.57) PPARGPPARAPTGESALOX5NPC1
SCHEMBL6718066 0.83 NPC1 (0.58) PPARGPPARAPTGESALOX5NPC1
SCHEMBL6715213 0.83 RARB (0.53) PPARGPPARAPTGESALOX5NPC1
SCHEMBL6713175 0.83 PPARG (0.52) PPARGPPARAPTGESALOX5NPC1
SCHEMBL6715909 0.82 EPHX2 (0.43) PPARGPPARAPTGESALOX5NPC1
SCHEMBL6715687 0.82 NPC1 (0.52) PPARGPPARAPTGESALOX5NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6528525-B1 Amidocarboxylic acid derivatives SANKYO COMPANY, LIMITED (JP) 2003-03-04 US claimed
EP-1026149-A1 AMIDOCARBOXYLIC ACID DERIVATIVES Sankyo Company Limited (JP) 2000-08-09 EP claimed
US-20040006141-A1 Amidocarboxylic acid compounds SANKYO COMPANY, LTD (JP) 2004-01-08 US disclosed
US-6528525-B1 Amidocarboxylic acid derivatives SANKYO COMPANY, LIMITED (JP) 2003-03-04 US disclosed
EP-1026149-A1 AMIDOCARBOXYLIC ACID DERIVATIVES Sankyo Company Limited (JP) 2000-08-09 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040006141-A1 Amidocarboxylic acid compounds NR1H2, AGK, APOL1 PPARG 23/4885PPARA 71/4885PTGES 547/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.